Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hudson

Showing results (371-380 of 560) with videos related to

Pageof 56
Sort By:
Journal of Medicinal Chemistry|July 1, 1981
Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonistsD L Lattin, B Caviness, R G Hudson, et al.
Cancer Research|March 23, 2005
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cellsJaime Symowicz, Brian P Adley, Michelle M M Woo, et al.
The Journal of Biological Chemistry|February 13, 2007
The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domainJeong Suk Kang, Clifford E Kashtan, A Neil Turner, et al.
The Journal of Biological Chemistry|May 30, 2006
Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3Corina M Borza, Ambra Pozzi, Dorin-Bogdan Borza, et al.
Urological Research|November 18, 2005
Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluriaJon I Scheinman, Paul A Voziyan, John M Belmont, et al.
Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Experimentale|December 18, 2018
Short- and long-term memory tasks predict working memory performance, and vice versaIan Neath, Jean Saint-Aubin, Tamra J Bireta, et al.
The Journal of Biological Chemistry|March 25, 1985
Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigenR J Butkowski, J Wieslander, B J Wisdom, et al.
Biochemistry|April 16, 1996
Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studiesR G Khalifah, P Todd, A A Booth, et al.
The Journal of Biological Chemistry|March 29, 2021
Collagen IV<sup>α345</sup> dysfunction in glomerular basement membrane diseases. III. A functional framework for α345 hexamer assemblyVadim Pedchenko, Sergei P Boudko, Mary Barber, et al.
The Journal of Biological Chemistry|September 17, 2003
Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ionsPaul A Voziyan, Raja G Khalifah, Christophe Thibaudeau, et al.
Pageof 56

Showing results (371-380 of 560) with videos related to

Sort By:
Pageof 56
Journal of Medicinal Chemistry|July 1, 1981
Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonistsD L Lattin, B Caviness, R G Hudson, et al.
Cancer Research|March 23, 2005
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cellsJaime Symowicz, Brian P Adley, Michelle M M Woo, et al.
The Journal of Biological Chemistry|February 13, 2007
The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domainJeong Suk Kang, Clifford E Kashtan, A Neil Turner, et al.
The Journal of Biological Chemistry|May 30, 2006
Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3Corina M Borza, Ambra Pozzi, Dorin-Bogdan Borza, et al.
Urological Research|November 18, 2005
Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluriaJon I Scheinman, Paul A Voziyan, John M Belmont, et al.
Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Experimentale|December 18, 2018
Short- and long-term memory tasks predict working memory performance, and vice versaIan Neath, Jean Saint-Aubin, Tamra J Bireta, et al.
The Journal of Biological Chemistry|March 25, 1985
Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigenR J Butkowski, J Wieslander, B J Wisdom, et al.
Biochemistry|April 16, 1996
Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studiesR G Khalifah, P Todd, A A Booth, et al.
The Journal of Biological Chemistry|March 29, 2021
Collagen IV<sup>α345</sup> dysfunction in glomerular basement membrane diseases. III. A functional framework for α345 hexamer assemblyVadim Pedchenko, Sergei P Boudko, Mary Barber, et al.
The Journal of Biological Chemistry|September 17, 2003
Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ionsPaul A Voziyan, Raja G Khalifah, Christophe Thibaudeau, et al.
Pageof 56